Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population.

Crivello ML, Ruth K, Sigurdson ER, Egleston BL, Evers K, Wong YN, Boraas M, Bleicher RJ.

Ann Surg Oncol. 2013 Jan;20(1):102-10. doi: 10.1245/s10434-012-2571-4. Epub 2012 Aug 10.

2.

A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.

Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, Eisinga A, Andronis L, Arvanitis T, Deeks J, Hyde C.

Health Technol Assess. 2010 Oct;14(50):1-103. doi: 10.3310/hta14500. Review.

3.

Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.

Grueneisen J, Nagarajah J, Buchbender C, Hoffmann O, Schaarschmidt BM, Poeppel T, Forsting M, Quick HH, Umutlu L, Kinner S.

Invest Radiol. 2015 Aug;50(8):505-13. doi: 10.1097/RLI.0000000000000197.

PMID:
26115367
4.

High-cost imaging in elderly patients with stage IV cancer.

Hu YY, Kwok AC, Jiang W, Taback N, Loggers ET, Ting GV, Lipsitz SR, Weeks JC, Greenberg CC.

J Natl Cancer Inst. 2012 Aug 8;104(15):1164-72. doi: 10.1093/jnci/djs286. Epub 2012 Jul 31.

5.

Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?

Hahn EE, Tang T, Lee JS, Munoz-Plaza CE, Shen E, Rowley B, Maeda JL, Mosen DM, Ruckdeschel JC, Gould MK.

Cancer. 2016 Mar 15;122(6):908-16. doi: 10.1002/cncr.29811. Epub 2015 Dec 9.

6.

Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?

Cho H, Lee HY, Kim J, Kim HK, Choi JY, Um SW, Lee KS.

J Thorac Cardiovasc Surg. 2015 Sep;150(3):514-20. doi: 10.1016/j.jtcvs.2015.06.024. Epub 2015 Jun 18.

PMID:
26189165
7.

Quality of post-treatment surveillance of early stage breast cancer in Texas.

Parmar AD, Sheffield KM, Vargas GM, Han Y, Chao C, Riall TS.

Surgery. 2013 Aug;154(2):214-25. doi: 10.1016/j.surg.2013.04.004.

8.

Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs.

Falchook AD, Salloum RG, Hendrix LH, Chen RC.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):243-8. doi: 10.1016/j.ijrobp.2013.10.023. Epub 2013 Dec 7.

PMID:
24321784
9.

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.

Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E.

Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040. Review.

10.

Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer.

Killelea BK, Long JB, Chagpar AB, Ma X, Soulos PR, Ross JS, Gross CP.

Breast Cancer Res Treat. 2013 Aug;141(1):155-63. doi: 10.1007/s10549-013-2656-1. Epub 2013 Aug 14.

11.

Variations in use of imaging in a national sample of men with early-stage prostate cancer.

Saigal CS, Pashos CL, Henning JM, Litwin MS.

Urology. 2002 Mar;59(3):400-4.

PMID:
11880080
12.

Variation in positron emission tomography use after colon cancer resection.

Bailey CE, Hu CY, You YN, Kaur H, Ernst RD, Chang GJ.

J Oncol Pract. 2015 May;11(3):e363-72. doi: 10.1200/JOP.2014.001933. Epub 2015 Apr 7.

13.

Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.

Yi CA, Lee KS, Lee HY, Kim S, Kwon OJ, Kim H, Choi JY, Kim BT, Hwang HS, Shim YM.

Cancer. 2013 May 15;119(10):1784-91. doi: 10.1002/cncr.28000. Epub 2013 Feb 19. Erratum in: Cancer. 2013 Aug 15;119(16):3102.

14.

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.

Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G, Fontanillas M, Pons F.

J Clin Oncol. 2008 Oct 10;26(29):4746-51. doi: 10.1200/JCO.2008.17.1496. Epub 2008 Aug 11.

PMID:
18695254
15.

Positron emission tomography and bone metastases.

Fogelman I, Cook G, Israel O, Van der Wall H.

Semin Nucl Med. 2005 Apr;35(2):135-42. Review.

PMID:
15765376
16.

Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.

An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.

Nuklearmedizin. 2014;53(3):89-94. doi: 10.3413/Nukmed-0605-13-06. Epub 2013 Nov 13.

PMID:
24220324
17.

Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.

Ng SP, David S, Alamgeer M, Ganju V.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):111-7. doi: 10.1016/j.ijrobp.2015.05.012. Epub 2015 May 15.

PMID:
26279029
18.

Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.

Meads C, Auguste P, Davenport C, Małysiak S, Sundar S, Kowalska M, Zapalska A, Guest P, Thangaratinam S, Martin-Hirsch P, Borowiack E, Barton P, Roberts T, Khan K.

Health Technol Assess. 2013 Mar;17(12):1-323. doi: 10.3310/hta17120. Review.

19.

FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.

Pan L, Han Y, Sun X, Liu J, Gang H.

J Cancer Res Clin Oncol. 2010 Jul;136(7):1007-22. doi: 10.1007/s00432-009-0746-6. Epub 2010 Jan 21.

20.

Use of high technology imaging for surveillance of early stage breast cancer.

Panageas KS, Sima CS, Liberman L, Schrag D.

Breast Cancer Res Treat. 2012 Jan;131(2):663-70. doi: 10.1007/s10549-011-1773-y. Epub 2011 Sep 24.

PMID:
21947679

Supplemental Content

Support Center